Global Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows

AbbVie

Market Cap: US$382.0b

A research-based biopharmaceutical company, engages in the research and development, manufacture, commercialization, and sale of medicines and therapies worldwide.

Hypera

Market Cap: R$14.9b

Operates as a pharmaceutical company in Brazil.

AstraZeneca

Market Cap: UK£176.7b

A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.

Exact Sciences

Market Cap: US$10.0b

Provides cancer screening and diagnostic test products in the United States and internationally.

Niagen Bioscience

Market Cap: US$758.4m

Operates as a bioscience company engages in developing healthy aging products.

Dizal (Jiangsu) Pharmaceutical

Market Cap: CN¥32.6b

Dizal (Jiangsu) Pharmaceutical Co., Ltd. discovers, develops, and commercializes medicines in the areas of cancer and immunological diseases.

Takara Bio

Market Cap: JP¥115.8b

Engages in the businesses of reagents, equipment, contract services, and genetic medicine in Japan, China, the rest of Asia, the United States, Europe, and internationally.

Eurofins Scientific

Market Cap: €11.1b

Provides various analytical testing and laboratory services worldwide.

Hugel

Market Cap: ₩3.4t

Develops and manufactures biopharmaceuticals in South Korea and internationally.

Rhythm Pharmaceuticals

Market Cap: US$6.3b

A commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases.

Everest Medicines

Market Cap: HK$20.8b

A biopharmaceutical company, engages in the discovery, license-in, development, and commercialization of therapies and vaccines to address critical unmet medical needs in Greater China and other Asia Pacific markets.

Zhejiang Jolly PharmaceuticalLTD

Market Cap: CN¥12.3b

Engages in the research, production, and marketing of Chinese medicinal products in the People’s Republic of China and internationally.

Essex Bio-Technology

Market Cap: HK$3.0b

An investment holding company, develops, manufactures, and sells biologic drugs in China, Hong Kong, and internationally.

Shanghai OPM Biosciences

Market Cap: CN¥6.0b

Provides cell culture media and CDMO services in China and internationally.

AprilBioLtd

Market Cap: ₩628.5b

AprilBio Co., Ltd. develops long-acting type biobetter and antibody biologics.

SK Biopharmaceuticals

Market Cap: ₩8.4t

A pharmaceutical company, engages in the research and development of drugs for the treatment of central nervous system disorders.

Ligand Pharmaceuticals

Market Cap: US$3.3b

A biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide.

Bonesupport Holding

Market Cap: SEK 19.7b

An orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.

Vitrolife

Market Cap: SEK 17.6b

Provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas.

BioLife Solutions

Market Cap: US$1.2b

Develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally.

Galderma Group

Market Cap: CHF 34.5b

Operates as a dermatology company worldwide.

BioGaia

Market Cap: SEK 10.7b

A healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand.

Akeso

Market Cap: HK$120.7b

A biopharmaceutical company, engages in the research, development, manufacture, and commercialization of antibody drugs worldwide.

Biocon

Market Cap: ₹491.6b

Manufactures and sells biotechnology products and research services in India, the United States, Ireland, rest of the European Union, and internationally.

Eli Lilly

Market Cap: US$686.5b

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally.

Cantourage Group

Market Cap: €45.9m

Operates as a medical cannabis company in Europe.

Caris Life Sciences

Market Cap: US$9.5b

An artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally.

PharmaResearch

Market Cap: ₩6.3t

Operates as a biopharmaceutical company primarily in South Korea.

InnoCare Pharma

Market Cap: HK$33.1b

A biopharmaceutical company, engages in discovering, developing, and commercializing drugs for the treatment of cancer and autoimmune diseases in China.

Sotera Health

Market Cap: US$4.6b

Provides sterilization, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally.

Nanjing Vazyme Biotech

Market Cap: CN¥8.9b

Offers technology solutions for life science, biomedicine, and in vitro diagnostics.

Simcere Pharmaceutical Group

Market Cap: HK$33.9b

An investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products to distributors, pharmacy chains, and other pharmaceutical manufacturers in China.

Repligen

Market Cap: US$6.7b

A life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally.

LigaChem Biosciences

Market Cap: ₩5.4t

A clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs.

Sichuan Kelun-Biotech Biopharmaceutical

Market Cap: HK$116.6b

A biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of novel drugs in oncology, immunology, and other therapeutic areas in the People’s Republic of China and internationally.

Laboratorios Farmaceuticos Rovi

Market Cap: €3.0b

Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.